US$ 25.68
history of glp 1 agonists glucagon-like peptide-1 receptor History of GLP-1: From Discovery
Description
As noted by Manasyan et al., while these agents reduce insulin requirements and maintain adequate glucose control with fewer hypoglycemic events, they may simultaneously impede adequate nutrition as a result of delayed gastric emptying and present a risk of aspiration

So, ditch the diet sodas (actually all sodas!)

Both Mounjaro and Ozempic are FDA-approved to treat type 2 diabetes but used off-label to treat obesity, explains Dr

The potential actions of GLP-1 medicines in modulating astrocyte-mediated neuroinflammation have not been extensively explored

As is reflective of the wider under-recognition of women in science, women's contributions to the development of GLP-1 drugs have taken time to be fully appreciated (Barany, Barany)
